We serve Chemical Name:(3-Bromopropyl)(triphenyl)phosphonium bromide CAS:3607-17-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(3-Bromopropyl)(triphenyl)phosphonium bromide
CAS.NO:3607-17-8
Synonyms:3-bromopropyl(triphenyl)phosphanium,bromide;MFCD00011866;(3-Bromopropyl)triphenylphosphonium bromide;Phosphonium, (3-bromopropyl)triphenyl-, bromide;3-Bromopropyltriphenylphosphonium Bromide;(3-Bromopropyl)(triphenyl)phosphonium bromide;(3-BROMO-PROPYL)-TRIPHENYL-PHOSPHONIUM,BROMIDE;Phosphonium, (3-bromopropyl)triphenyl-, bromide (1:1);EINECS 222-770-9
Molecular Formula:C21H21Br2P
Molecular Weight:464.173
HS Code:2931900090
Physical and Chemical Properties:
Melting point:228-230 °C(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:13.59000
Exact Mass:461.974762
LogP:1.76950
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 3-bromopropyl(triphenyl)phosphanium,bromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 222-770-9 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00011866 Use and application,3-Bromopropyltriphenylphosphonium Bromide technical grade,usp/ep/jp grade.
Related News: Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. (3-Bromopropyl)(triphenyl)phosphonium bromide manufacturer To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. (3-Bromopropyl)(triphenyl)phosphonium bromide supplier Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. (3-Bromopropyl)(triphenyl)phosphonium bromide vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. (3-Bromopropyl)(triphenyl)phosphonium bromide factory To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early.
